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Available online 9 April 2016Micro-computed tomography (micro-CT) is used routinely to quantify skeletal tissue mass in small animal
models. Our goal was to evaluate repeated in vivomicro-CT imaging for monitoring whole-body composition
in studies of growth and aging in mice. Male mice from 2 to 52 weeks of age were anesthetized and imaged
using an eXplore Locus Ultra and/or eXplore speCZT scanner. Images were reconstructed into 3D volumes,
signal-intensity thresholds were used to classify each voxel as adipose, lean or skeletal tissue, and tissue masses
were calculated from known density values. Images revealed speciﬁc changes in tissue distribution with growth
and aging. Quantiﬁcation showed biphasic increases in total CT-derived body mass, lean and skeletal tissue
masses, consisting of rapid increases to 8weeks of age, followed by slow linear increases to 52weeks. In contrast,
bonemineral density increased rapidly to a stable plateau at ~14 weeks of age. On the other hand, adipose tissue
mass increased continuously with age. A micro-CT-derived total mass was calculated for each mouse and
compared with gravimetrically measured mass, which differed on average by b3%. Parameters were highly re-
producible for mice of the same age, but variability increased slightly with age. There was also good agreement
in parameters for the same group of mice scanned on the eXplore Locus Ultra and eXplore speCZT systems.
This study provides reference values for normative comparisons; as well, it demonstrates the usefulness of
in vivo single-energy micro-CT scans to quantify whole-body composition in high-throughput studies of growth
and aging in mice.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Mouse models are increasingly important in biomedical research
due to their ease of genetic manipulation, ability to mimic human
diseases, small body size, and relatively affordable costs (Rosenthal
and Brown, 2007). When using animal models, it is important to have
reference values for normative comparisons. Mouse strains often used
in research today include C57BL/6, BALB/c, 129 substrains, C3H and
DBA/2 mice (Crawley et al., 1997; Beck et al., 2000; Buie et al., 2008;
Hankenson et al., 2008). Descriptions of the most commonly used
C57BL/6 mouse include masses of wet and dry individually-isolated
bones, and bone mineral density (BMD) and bone mineral content
(BMC) of speciﬁc bones (e.g., tibia and femur) obtained usingl of Medicine & Dentistry, The
ada.
rch Institute, Schulich School of
London, ON N6A 5C1, Canada.
. Beaucage),
. This is an open access article underdestructive or imaging methods (Sheng et al., 1999; Brochmann et al.,
2003; Somerville et al., 2004; Glatt et al., 2007). Althoughmany param-
eters can be measured post-mortem, longitudinal in vivo studies of
growing and aging mice were not possible until the advent of non-
invasive imagingmodalities. It is now important to establish safe, effec-
tive and reproducible approaches for assessing whole-body composi-
tion in vivo and to establish normal reference values for growing and
aging mice.
Several in vivo imaging modalities exist for determining skeletal
phenotypes in animals, each with differing strengths and weaknesses.
Dual-energy X-ray absorptiometry (DXA) is a simple approach to
determine areal BMD (aBMD) and is used for clinical diagnosis and
monitoring the progression of bone diseases such as osteoporosis
(Pisani et al., 2013). Determination of fat content from the scans is
also possible (Pietrobelli et al., 1996; Sjogren et al., 2001; Senn et al.,
2007; Halldorsdottir et al., 2009). However, DXA does not distinguish
between cortical and trabecular bone, and is known to overestimate
or underestimate the density of large or small bones, respectively
(Judex et al., 2003). When using small animal models such as mice,
the accuracy of measurement is critical; therefore, CT methods arethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Mouse cohorts.
Cohort 1 2 3 4 Total
Age (weeks) 2–8 8–26 39 52 2–52
Number of mice (n) 8 8 8 7 31
Whole-body scans usingmicro-computed tomographywere performed on four cohorts of
male mice. In cohort 1, the same mice were scanned at three-week intervals (2, 5 and 8
weeks of age). Cohort 2 mice were scanned at three week-intervals (from 8 to 26 weeks
of age). Cohort 3 was scanned only at 39 weeks and cohort 4 only at 52 weeks of age.
All cohorts were scanned using the eXplore Locus Ultra system, and cohort 1 was also
scanned using the eXplore speCZT system.
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phy (HR-pQCT) is amethod used clinically to determine BMD in periph-
eral long bones of human patients (Cheung et al., 2013) and has also
been used to quantify BMD and bone microarchitecture in rodents
(Beamer et al., 1996; Richman et al., 2001; Bagi et al., 2006). High-
resolution magnetic resonance imaging (HR-MRI) can be used to
quantify soft and hard tissues. Although radiation is not an issue in
this method, high-resolution images for bone morphometry require
long scan times (Donnelly, 2011). Another CT method to determine
BMD is synchrotron radiation micro-CT (SRmuCT). Although SRmuCT
yields images with high spatial resolution and excellent signal-to-
noise ratio, it has more commonly been used for ex vivo rather than
in vivo studies (Donnelly, 2011; Martin-Badosa et al., 2003; Ito et al.,
2003; Ito, 2005; Raum et al., 2007). Furthermore, a limitation of this
modality is that few synchrotron facilities are available (Donnelly,
2011). Therefore, the widely available technology of micro-computed
tomography (micro-CT) has become a popular choice for assessment
of BMD and bone microarchitecture (Kazakia et al., 2008).
Micro-CT is the gold standard for morphologic assessment and
quantiﬁcation of radio-opaque tissues in small samples (Donnelly,
2011; MacNeil and Boyd, 2007), including evaluation of skeletal anato-
my, abnormalities and morphometry in rodent models (Hankenson
et al., 2008; Ford-Hutchinson et al., 2003). Moreover, micro-CT has
several advantages: it is designed speciﬁcally for imaging and analysis
of small samples at high-resolution; some systems have the capacity
to perform scans of whole animals such as small rodents; in vivo scans
can be obtained rapidly without sacriﬁcing animals; and longitudinal
studies with repeated scanning of animals are possible with low radia-
tion exposure (Glatt et al., 2007; Judex et al., 2003; Granton et al.,
2010). In addition, advanced micro-CT imaging allows for accurate
quantiﬁcation of soft-tissue volumes. This permits assessment of
whole-body composition (WBC) in vivo, including total body, adipose,
lean and skeletal tissue parameters (Granton et al., 2010), which
previously could only be evaluated post-mortem using the other imag-
ing modalities mentioned above. Concomitant evaluation of adipose,
lean and skeletal tissues will become critical in animal models as inter-
connected roles closely link these tissues and their functions together
(Migliaccio et al., 2014; Tagliaferri et al., 2015). Although advanced
in vivomicro-CT imaging is an emerging technique to monitor growth
including normal and abnormal skeletogenesis in rodents (Guldberg
et al., 2004), harnessing the power of micro-CT for WBC analyses in a
rapid and comprehensive manner has been greatly overlooked. This
may be attributed to the fact that advanced image analysis can be
quite time consuming and tedious, as large data sets can take hundreds
of hours to quantify using conventional approaches. Therefore, as
micro-CT has become a preferred imaging modality for quantiﬁcation
of WBC in small animals, the need for high-throughput methods of
analysis becomes increasingly urgent.
In the present study, we report the ﬁrst use of micro-CT to monitor
and repeatedly quantify WBC in groups of mice during growth and
aging. WBC analysis was enabled by in-house-designed software,
which quantiﬁes whole-body parameters from scanned images, based
on threshold density values of speciﬁc tissues and phantom calibrators.
Although others have previously reported densities and characteris-
tics of speciﬁc bones (Somerville et al., 2004; Glatt et al., 2007; Miller
et al., 2007), there have been no previous studies using in vivomicro-
CT to quantify changes in WBC of mice during growth and aging. In
the present study, cohorts of mice were scanned at 3-week intervals
from 2 to 8 weeks of age and from 8 to 26 weeks of age, with addi-
tional groups scanned at 39 and 52 weeks of age. Outcome values
included: total body mass (g); adipose, lean and skeletal tissue
masses (g) and mass percentages (%); bone mineral density (BMD,
mg HA/cm3); and bone mineral composition (BMC, mg HA). Femur
and tibia lengths were measured using anatomical markers, and
maximum BMD of femoral mid-diaphyses was quantiﬁed. Variability
and internal validity of the scanning protocol were assessed. Ourﬁndings establish that non-invasive single-energy micro-CT is an ac-
curate and effective tool for characterizing the WBC of mice during
growth and aging.
2. Materials and methods
2.1. Animals
Mice, maintained on amixed genetic background of commonly used
strains (C57BL/6 × 129/Ola × DBA/2), were housed in standard cages
and maintained on a 12-hour light/dark cycle, with water and standard
mouse chow available ad libitum (2018 Teklad Global 18% protein ro-
dent diet, Harlan Laboratories, Indianapolis, IN, USA). This study was
conducted in accordancewith the policies and guidelines of the Canadi-
an Council on Animal Care and was approved by the Animal Use
Subcommittee of The University of Western Ontario, London, Canada.
Four cohorts of mice were studied. For cohort 1, the same mice were
scanned at 2, 5 and 8 weeks of age. The mice in cohort 2 were scanned
at three-week intervals from 8 to 26 weeks of age, inclusive. Cohort 3
mice were studied at 39 weeks of age. Finally, the mice in cohort 4
were scanned at 52 weeks of age (Table 1).
2.2. Micro-computed tomography (micro-CT) image acquisition
Whole-body composition of mice between 2 and 52 weeks of age
was assessed using micro-CT. Mice were anesthetized with isoﬂurane
(Forane, catalog # CA2L9100, Baxter Corporation, Mississauga, ON,
Canada) and imaged using an eXplore Locus Ultra micro-CT scanner
and/or an eXplore speCZT scanner (GE Healthcare Biosciences,
London, ON, Canada). A calibrating phantom composed of air, water
and cortical bone-mimicking epoxy having a bone mineral equivalent
of 1100 mg/cm3 (SB3; Gammex, Middleton, WI, USA) (White, 1978)
was scanned together with the animals. On the eXplore Locus Ultra
scanner, 1000 projection images were obtained over a single 16-
second rotation (80 kVp, 55 mA tube current, 16 ms exposure). On the
eXplore speCZT scanner, 900 projection images were obtained over a
single 5-minute rotation (90 kVp, 40mA tube current, 16ms exposure).
Entrance doses were 9 cGy for scans on the eXplore Locus Ultra micro-
CT and 22 cGy on the eXplore speCZT, determined using a model
35614 dosimeter (Keithley Instruments, Cleveland, OH). Previous stud-
ies have shown that the LD50/30 for mice is 5–7.6 Gy (Mole, 1957; Kohn
and Kallman, 1957; Sato et al., 1981); our protocol was able to perform
repeated longitudinal imaging while maintaining an acceptably low
radiation dose of 9–22 cGy per scan. Moreover, other studies have
shown that rodents are able to rapidly recover from individual and re-
peated exposures of 25–30 cGy, without affecting animal survival
(Mole, 1957; Parkins et al., 1985). While still anesthetized immediately
after scanning, mice were gravimetrically weighed using a portable
electronic precision scale (Acculab VICON VIC-511; Sartorius Group,
Germany).
Data sets were reconstructed into 3D volumes from the X-ray
projection data with nominal isotropic voxel spacing of 154 μm
(eXplore Locus Ultra) and 50 μm (eXplore speCZT) using a cone-beam
ﬁltered backprojection algorithm. The 50 μm volumes from the eXplore
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to-noise characteristics of the volume) and 150 μm (to compare with
data from the eXplore Locus Ultra). Using images of the calibrating
phantom, reconstructed data were linearly rescaled into Hounsﬁeld
units (HU), with the voxel gray-level of air being −1000 HU and
water 0 HU.2.3. Analysis of whole-body composition
Using MicroView software (GE Healthcare Biosciences), three
signal-intensity thresholds (−200,−30 and 190HU)were used to clas-
sify each voxel as adipose (−200 to−31HU), lean (−30 to 189HU), or
skeletal tissue (≥190 HU), respectively for the 154 and 150 μm scans. A
different set of global thresholds was determined using MicroView for
classiﬁcation of adipose, lean and skeletal tissue for the 100 μm scans
(−275,−40 and 250 HU, respectively). The signal-intensity thresholds
were determined visually by applying thresholds to CT-derived data
from several mice at each age to properly classify tissues based on ana-
tomical locations and calibration standards, as validated previously in
rodent and human data sets (Granton et al., 2010; Wyatt et al., 2015;
Buie et al., 2007). In-house-designed software was used to calculate tis-
sue masses from tissue densities of 0.95 (adipose), 1.05 (lean) and 1.92
(skeletal) g/cm3, as listed by the International Commission on Radiation
Units and Measurements (ICRU, 1989). The software computed the
tissue masses ﬁrst by calculating the volume of voxels (in cm3) for
each of adipose, lean, and bone tissue using the signal-intensity thresh-
olds described above (Granton et al., 2010; Beaucage et al., 2014). Once
the volume of each tissue was calculated, its contributing mass was
computed as the product of the tissue volume and the corresponding
tissue density. The sum of all tissue masses yielded a CT-derived esti-
mate of whole-body mass. In addition, the software was used to calcu-
late BMD and BMC. Brieﬂy, BMD was computed as the ratio of the
average HU value of the skeletal region of interest (ROI) to the mea-
sured HU value of the SB3 calibrator, multiplied by the known hydroxy-
apatite (HA)-equivalent density of the SB3 (1100 mg/cm3). Thereafter,
the program automatically computed BMC as the product of the BMD
(mg HA/cm3) and the total volume of the skeletal ROI used in the
BMD calculation.2.4. Hind-limb long-bone length
Bone lengths were determined using the line measurement tool in
MicroView. Femurs were measured from the base of the lateral femoral
condyle to the tip of the greater trochanter. Tibial lengths were mea-
sured from the base of the medial malleolus to the tip of the
intercondylar eminence.Table 2
Percent change of whole-body composition parameters with growth and aging.
2 weeks of age
Mean ± S.D.
52 weeks of age
Mean ± S.D.
Percent
increase
CT-derived total body mass (g) 7.8 ± 0.2 36.3 ± 1.2 364
Adipose tissue mass (g) 1.8 ± 0.3 10.1 ± 2.6 463
Lean tissue mass (g) 4.8 ± 0.2 21.3 ± 1.2 341
Skeletal tissue mass (g) 1.2 ± 0.1 4.8 ± 0.1 306
BMD (mg HA/cm3) 171.2 ± 6.8 339.6 ± 6.3 98
BMC (mg HA) 105.8 ± 14.5 850.9 ± 37.0 704
Data represent means ± S.D. of the indicated parameters obtained from scans on the eX-
plore Locus Ultra of mice at 2weeks of age and 52weeks of age (n=8 and 7mice, respec-
tively). All parameters were signiﬁcantly greater at 52 weeks of age compared to their
values at 2 weeks of age (p b 0.05 determined using unpaired two-tailed Student's t-test).2.5. Determination of maximum bone mineral density
The maximum value of BMD was determined for an ROI that
encompassed the mid-diaphysis of the left femur. The ROI was 33% of
the total femur length along the long axis and spatially encompassed
the entire mid-diaphysis in the other axes. In-house-designed software
was used to determine the maximum BMD value for each femur. For
consistency, when assessing these BMD values in Cohort 1 mice using
100 μm eXplore speCZT scans, we used the same threshold value as
above for skeletal tissue (250 HU). Similarly, when assessing the BMD
in skeletally mature mice (Cohorts 2–4) using 154 μm eXplore Locus
Ultra scans, we used the same threshold value as above for skeletal tis-
sue (190 HU). For each ROI, a histogram of BMD values was generated,
plotting the gray level frequency versus the gray level from the indicated
skeletal thresholds to the maximum value. The maximum BMDwas re-
ported as the 95th percentile of this histogram.2.6. Statistical analyses
Data are presented as means ± standard deviation (S.D.). Differ-
ences between two groupswere assessed using the Student's t-test. Dif-
ferences among three or more groups were evaluated by two-way
analysis of variance followed by a Bonferroni multiple comparisons
test. Curves were ﬁt to growth data (total body mass, lean and skeletal
tissue mass, BMD and BMC) by non-linear least squares regression
using two-phase association in GraphPad Prism software version 5
(GraphPad Software Inc., La Jolla, CA, USA). Curves were ﬁt to growth
data for adipose tissue mass by non-linear least squares regression
using an exponential growth equation in GraphPad Prism. Differences
were accepted as statistically signiﬁcant at p b 0.05. All n values
represent the number of mice used in each group.
3. Results
3.1. Imaging whole-body composition of mice during growth and aging
A total of 31 male mice, divided into four cohorts, were assessed
using in vivo quantitative micro-CT at speciﬁc ages (Table 2). Scans ob-
tained using the eXplore Locus Ultra micro-CT were reconstructed with
nominal isotropic voxel spacing of 154 μm and rescaled into Hounsﬁeld
units. An in-house-designed program was used to assign each voxel as
adipose, lean or skeletal tissue, based on threshold values. Representa-
tive mid-coronal images demonstrate the pattern of changes in
whole-body composition during growth and aging (Fig. 1). At 2 weeks
of age, the mice had a large amount of adipose tissue (blue) relative to
their body size, which appeared to be primarily subcutaneous fat. At
this age, the skeleton was still developing, as evident by the larger
relative size of the appendicular skeletal elements and skull relative to
overall body size, as well as incomplete mineralization of caudal verte-
brae. By 5 weeks of age, we saw a marked reduction in subcutaneous
adipose tissue accompanied by a corresponding increase in the propor-
tion of lean tissue. At 52weeks of age, mice exhibited amarked increase
in visceral adiposity at the expense of lean tissue. These examples illus-
trate that 3Dmicro-CT images with appropriate thresholding can reveal
the localization of tissue types within the body and changes in their
distribution with growth and aging.
3.2. Quantiﬁcation of whole-body composition during growth and aging
Adipose, lean and skeletal tissue volumeswere converted into tissue
masses bymultiplying each volume by the respective tissue densities of
0.95, 1.05, and 1.92 g/cm3 (ICRU, 1989). Time course studies revealed
dramatic changes in body composition during growth, and more mod-
est changes during aging (Fig. 2). Total CT-derived body mass showed
an initial rapid increase from2 to 8weeks of age, followed by a slow lin-
ear increase to 52weeks of age (Fig. 2A). Lean and skeletal tissuemasses
and BMC displayed a pattern similar to that of total body mass (Fig. 2C,
E, F). In contrast, BMD rose rapidly until 11–14 weeks and then
plateaued (Fig. 2B). Unlike other parameters, adipose tissue mass
Fig. 1.Representativemicro-CT images of whole-body composition showing total adipose lean and skeletal tissues. Cohorts ofmalemice at several ageswere anesthetized for whole-body
scans using the eXplore Locus Ultra micro-CT. Scans were reconstructedwith nominal isotropic voxel spacing of 154 μmand rescaled into Hounsﬁeld units using the same protocol for all
ages. An in-house-designed programwas used to assign each voxel as adipose lean or skeletal tissue based on threshold values. Each row shows the samemid-coronal slice from a single
representativemouse at each age indicated on the left. Imageswere overlaidwith the identiﬁed skeletal tissue (shown inwhite as surface-rendered images of the highest quality with no
decimation). Second and third columns show adipose tissue (blue) and lean tissue (red) respectively. High-density particles in the abdomen ofmice from 5 to 52weeks of age arose from
material in the animal chow. Scale bar represents 1 cm at each age point. Images are representative of at least 7 mice at each age point.
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Fig. 2. Cohorts of male mice were imaged as described in the legend to Fig. 1. In-house-designed software was used to calculate tissue masses from assumed tissue densities of 0.95
(adipose), 1.05 (lean), and 1.92 (skeletal) g/cm3, respectively. Total body mass (A) exhibited an initial rapid increase from 2 to 8 weeks of age, followed by a slow linear increase to
52 weeks. Bone mineral density (BMD, B) also showed a rapid increase until 11–14 weeks of age, but in this case was followed by a plateau. Bone mineral content (BMC, C) and lean
and skeletal tissue masses (E, F) showed patterns similar to (A). In contrast, adipose tissue mass (D) displayed a distinct pattern, increasing continuously with the rate of increase
rising with age. Data points for 8-week-old mice in cohorts 1 and 2 are plotted overlaid in each graph. Data are means ± S.D., n ≥ 7 mice per age group. Curves were ﬁt by non-linear
least squares regression.
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(Fig. 2D). The percent change in whole-body composition parameters
was calculated between 2 and 52 weeks of age (Table 2). We found
that lean and skeletal masses increased 300–350%, whereas adipose
tissue mass showed a larger relative increase of over 460%. BMD
doubled and BMC increased 7-fold, reﬂecting both the increase in
BMD and growth in skeletal mass over time.
We next assessed the variability in whole-body composition param-
eters among mice at each age. Fig. 3 illustrates the range of values
observed for each individual mouse. Variability was also quantiﬁed as
the coefﬁcient of variation (Table 3). Variability in CT-derived total
body mass was relatively constant at each age (Fig. 3A), with coefﬁ-
cients of variation ranging from 7 to 9%. On the other hand, coefﬁcients
of variation for BMD and BMC were larger at 2 weeks of age decreasing
to 1–2% and 4–5% in older age groups, respectively (Fig. 3B and C).
Adipose tissue mass showed greatest variability (Fig. 3D), with coefﬁ-
cients ranging from 16% at 2 weeks of age to 26–33% in older mice.
Variability of lean tissuemass was relatively constant (Fig. 3E), with co-
efﬁcients ranging between 4 and 6%; whereas variability in skeletal
tissue mass decreased with aging (Fig. 3F), with the coefﬁcient of varia-
tion declining from 10% at 2 weeks to 3% at 52 weeks.
When tissue masses were expressed as a percentage of total body
mass, a large decrease in adipose tissue mass was apparent from 2 to
5 weeks of age, with a corresponding increase in lean tissue mass
(Fig. 3G and H). In contrast, the percentage of skeletal tissue remained
relatively constant with growth and aging (Fig. 3I).
3.3. Length of long bones during growth and aging
When characterizing skeletal phenotypes of mice, the assessment of
bone length has been a measurement frequently reported in the litera-
ture (Somerville et al., 2004; Glatt et al., 2007; Beamer et al., 1996; Brodt
et al., 1999). Therefore, to establish external validity, we determined the
lengths of hind-limb long bones using ourmicro-CT data sets. Using the
line measurement tool in MicroView software, the right and left tibiae
and femursweremeasured in the scanned volume of eachmouse. Tibiallengths were determined from the base of the medial malleolus to the
tip of the intercondylar eminence (Fig. 4A and B). Femoral length was
measured from the base of the lateral femoral condyle to the tip of the
greater trochanter (Fig. 4D and E). Both bones showed rapid growth –
over 2 to 8 weeks of age, tibial length increased from 10.5 to 16.3 mm
and femoral length increased from 8.7 to 15.3 mm. Thereafter, there
was only a slight increase in length to 17.3 mm for the tibia and
16.7 mm for the femur at 52 weeks of age. There were no signiﬁcance
differences between left and right bones at any age point (Fig. 4C and F).
3.4. Maximum bone mineral density
As regional variations in BMD occur within skeletal tissue, the
maximum BMD value within a deﬁned ROI better reﬂects the extent
of compact bone mineralization. Therefore, we assessed maximum
BMD of an ROI comprised of the mid-diaphyseal region of the femur.
MaximumBMD valueswere reported as the 95th percentiles of the den-
sities. These values displayed a rapid increase from 2 to 11weeks of age,
followed by a slow linear increase to 52weeks of age (Fig. 5). Values for
the 99th percentile showed a similar pattern as the 95th percentile,
reaching 1102 ± 38 mg HA/cm3 at 39 weeks of age, comparable to
previously reported values for cortical bone BMD in mice of 1100 to
1200 mg HA/cm3 (Windahl et al., 1999; Entezari et al., 2012). These
ﬁndings reveal that maximum BMD increases during growth in mice.
3.5. Internal validity, precision and reproducibility of scanning protocols
To assess reproducibility of the scanning protocol, we examined two
separate cohorts of mice at 8 weeks of age (C1 and C2). Both cohorts
were scanned using the eXplore Locus Ultra micro-CT. Images were
reconstructed with isotropic voxel spacing of 154 μm, rescaled into
Hounsﬁeld units and subjected to whole-body composition analysis.
Similar valueswere obtained for the two cohorts ofmice (Fig. 6). For ex-
ample, the differences in gravimetric and CT-derived total body masses
were only 2.9% and 2.5%, respectively. This similarity provided justiﬁca-
tion for combining data from the two cohorts of mice to obtain the time
Fig. 3. Variability of whole-body composition values. Images of male mice were obtained and analyzed as described in the legends to Figs. 1 and 2. Data points (black circles) represent
values of the indicated parameter for each individual mouse. Data show the vertical scatter for the age indicated numerically on the x-axis (horizontal scatter was introduced for
clarity only). Eight mice were imaged at each age except 52 weeks, where n= 7mice. Bars indicate mean ± S.D. for each age. Data for 8-week-old mice are presented for both cohorts
1 and 2. (A–F) illustrate parameters of whole-body composition in absolute values. (G–I) illustrate adipose, lean and skeletal tissue masses as a percentage of the total CT-derived body
mass.
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ence between total body masses measured gravimetrically and using
micro-CT.
Next, the relationship between gravimetric and CT-derived total
body mass was examined in greater detail. We compared the gravimet-
ric to the CT-derivedmass at all ages (Table 4). The computed totalmass
corresponded well with the weight of each mouse. The CT-derived
masses were consistently less than the gravimetrically measuredTable 3
Coefﬁcients of variation in whole-body composition values at selected ages.
Coefﬁcient of variation (%)
2 weeks of age 26 weeks of age 52 weeks of age
CT-derived total body mass 7.6 8.5 9.0
BMD 4.0 1.3 1.8
BMC 13.7 4.2 4.4
Adipose tissue mass 15.8 32.6 25.8
Lean tissue mass 4.3 5.2 5.8
Skeletal tissue mass 10.0 4.1 2.9
Male mice were scanned and images were analyzed as described in the legends to Figs. 1
and 2. Coefﬁcients of variation were calculated as the ratio of the S.D. to the mean,
expressed as a percentage. Eight mice were imaged at each age except 52 weeks, where
n= 7mice.masses, differing by b3%. Although small, this difference was signiﬁcant
in mice ≥17 weeks of age. These data provide internal validation of the
accuracy of our micro-CT-derived tissue mass measurements.
As described above,whole-body compositionwas assessed using the
eXplore Locus Ultra micro-CT scanner at 154 μm resolution. However,
the growing mice in cohort 1 (age 2–8 weeks) had smaller, less miner-
alized bones. Therefore, to conﬁrm the accuracy ofmeasurementsmade
using the eXplore Locus Ultra scanner, cohort 1 was also scanned at
higher resolution using the eXplore speCZT scanner. Images produced
using the eXplore speCZT scanner at 50 μm isotropic voxel spacing
were spatially-averaged to 100 and 150 μm. There were small, but in
some cases, statistically signiﬁcant differences in the CT-derived
measures of total mass, BMD, BMC, and adipose, lean and skeletal tissue
mass obtained using each scanner (Fig. 7). CT-derived total body mass,
BMC and lean tissue mass showed the least differences among
scan conditions (Fig. 7A,C, and E). Scans obtained using the eXplore
Locus Ultra appeared to underestimate adipose tissue mass relative to
those obtained using the eXplore speCZT scanner (Fig. 7D and G),
while slightly overestimating lean tissue mass (Fig. 7E and H). Interest-
ingly, images obtained using the eXplore speCZT scanner with 100 μm
voxel spacing, appeared to underestimate BMD relative to the other
conditions (Fig. 7B), while overestimating skeletal tissue mass (Fig. 7F
and I).
Fig. 4. Right and left tibiae and femurs were measured using the line measurement tool in MicroView from base of the medial malleolus to tip of the intercondylar eminence (for
tibiae, A‐B) and base of the lateral femoral condyle to tip of the greater trochanter (for femurs, D–E). Right and left tibia and femur bone lengths were overlaid respectively (C, F),
revealing no signiﬁcant differences between right and left limb lengths (p N 0.05, determined by two-way repeated measures ANOVA). Data are means ± S.D. Eight mice were
imaged at each age except 52 weeks, where n = 7 mice.
76 K.L. Beaucage et al. / Bone Reports 5 (2016) 70–80Taken together, these data establish that non-invasive single-energy
micro-CT is a valid, precise and reproducible tool for characterizingWBC
of mice during growth and aging.
4. Discussion
BMD and composition are commonly reported measures of bone
quantity and quality; these can be used to infer skeletal strength, frac-
ture risk and disease state (Donnelly, 2011; Kazakia et al., 2008;
Dougherty, 1996). Invasive methods have traditionally been used to
determine BMD and composition, requiring post-mortem studies of
whole bones in small animals. Destructive testing can be used to assess
microarchitecture, mechanical tests to determine strength and elasticFig. 5.Maximumbonemineral density.Mice from2 to 8weeks of agewere scannedon the
eXplore speCZT system at 50 μmand re-binned to 100 μm for these analyses.Mice from 11
to 52 weeks of age were scanned on the eXplore Locus Ultra system at 154 μm nominal
voxel spacing, as described in the legends of Figs. 1 and 2. Left femurs were cropped
from the whole-body images and axes were reoriented. A region of interest (ROI) that
encompassed the mid-diaphysis in all three spatial directions was cropped from each of
the volumes. The ROI, which included only cortical bone, was then used to determine
the maximum value of BMD. Data are means ± S.D., n = 7 mice per age group. The
curve was ﬁt by non-linear least squares regression.modulus, and ash measurements to reveal chemical composition
(Donnelly, 2011; Kazakia et al., 2008). Thesemethods are time consum-
ing, destructive and require sacriﬁcing the animal. Therefore, rapid,
quantitative and non-invasive alternatives are desirable. Imaging
modalities such as micro-CT have become a preferred avenue for
measuring BMD and microarchitecture of isolated bones, in addition
to assessing skeletal growth in vivo (Guldberg et al., 2004; Bouxsein
et al., 2010).Fig. 6. Reproducibility of whole-body composition determinations. Two separate cohorts
of 8-week-old male mice were imaged as described in the legend to Fig. 1 and then
weighed to determine gravimetric total body mass. Data were subsequently analyzed to
determine CT-derived total body mass and adipose, lean and skeletal tissue masses as
described in the legend to Fig. 2. Symbols represent values of the indicated parameter
for each individual mouse (ﬁlled black circles represent animals in cohort 1, and open
circles represent cohort 2). Bars are means ± S.D. Eight mice were imaged in each
cohort. There were no signiﬁcant differences between values of gravimetric and CT-
derived total body masses, providing validation of the micro-CT-derived tissue mass
measurements. In addition, there were no signiﬁcant differences in masses of adipose,
lean or skeletal tissue between cohorts 1 and2 (p N 0.05, determinedby two-wayANOVA).
Table 4
Gravimetric and CT-derived total body masses of mice at each age.
Age (weeks) Cohort
Gravimetric
mass (g)
Mean ± S.D.
CT-derived mass (g)
Mean ± S.D.
n % difference
2 1 8.0 ± 0.2 7.8 ± 0.2 8 1.9
5 1 19.5 ± 0.5 19.1 ± 0.6 8 1.7
8 1 24.3 ± 0.5 23.9 ± 0.5 8 1.6
8 2 23.6 ± 0.6 23.3 ± 0.6 8 1.6
8 1 + 2 24.0 ± 0.4 23.6 ± 0.4 16 1.6
11 2 22.7 ± 0.5 22.2* ± 0.5 8 2.2
14 2 23.1 ± 0.5 22.8 ± 0.5 8 1.5
17 2 24.0 ± 0.4 23.4* ± 0.4 8 2.3
20 2 24.8 ± 0.8 24.2* ± 0.7 8 2.4
23 2 25.8 ± 0.7 25.1* ± 0.7 8 2.8
26 2 26.2 ± 0.8 25.5* ± 0.8 8 2.9
39 3 33.2 ± 0.9 32.6* ± 0.9 8 2.1
52 4 37.2 ± 1.3 36.3* ± 1.2 7 2.5
Malemicewere imaged as described in the legend to Fig. 1 and thenweighed to determine
gravimetric total body mass. Data were subsequently analyzed to determine CT-derived
total body mass. For 8-week-old mice, data are shown for cohorts 1 and 2, individually
and combined. Data are means ± S.D. n equals the number of mice scanned. The percent
differences between means are shown in the right column. * Indicates signiﬁcance differ-
ence between gravimetrically andmicro-CT-derived total bodymasses (p b 0.05, assessed
by two-way repeated measures ANOVA with Bonferroni's post hoc test).
Fig. 7. Comparison of whole-body composition values determined using different scanners and
LocusUltra andeXplore speCZTmicro-CT scanners. Imageswere reconstructed to 154 μmfor the
respectively), and rescaled into Hounsﬁeld units. Each voxel was then assigned as adipose, lean
body composition in absolute values. (G–I) illustrate adipose, lean and skeletal tissuemasses as
cohort. a indicates signiﬁcant difference between the Ultra and speCZT 150 μm scans, b indi
signiﬁcant difference between the speCZT 150 μm and speCZT 100 μm scans (p b 0.05, determ
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composition with growth and aging in mice. Using non-invasive
micro-CT, we were able to repeatedly scan cohorts of mice over several
ages. Our results provide valuable reference data for researchers using
mouse models of development, aging and disease. The whole-body
masses measured using gravimetric and CT methods align well with
previous reports of age-related changes in gravimetric whole-body
mass of mice. Our mice more than doubled their body mass between
2 and 5 weeks of age, and exhibited ~50% increase between 4 and
8 weeks. Previous studies of growing male C57BL/6 mice reported a
more modest ~30% increase between 1 and 2 months (Glatt et al.,
2007), and a comparable ~47% increase in body mass (Somerville
et al., 2004). Moreover, between 4 and 52 weeks of age, we observed
an ~2.3-fold increase in body mass similar to previous reports of ~2.0
to 2.2-fold increase in body mass over the same period (Somerville
et al., 2004; Glatt et al., 2007; Halloran et al., 2002).
To the best of our knowledge, the present study is the ﬁrst to report
CT-derived whole skeleton data for mice. Previous studies have
reported CT-derived BMD for individual bones (vertebra, femur, tibia)
(Buie et al., 2008; Beamer et al., 1996; Richman et al., 2001;
Martin-Badosa et al., 2003; Amblard et al., 2003). We found that
whole-body BMD values increase until 11 to 14 weeks of age, then
plateau. Glatt and colleagues showed using DXA that whole-body
aBMD increased rapidly up to 4 months of age in C57BL/6 mice,voxel spacing. Cohort 1 mice were scanned at 2, 5 and 8 weeks of age on both the eXplore
eXplore LocusUltra (green), and150 μmand 100 μmfor the eXplore speCZT (red and blue,
or skeletal tissue, and tissuemasses were calculated. (A–F) illustrate parameters of whole-
a percentage of the CT-derived total bodymass. Data aremeans± S.D., n=8mice in each
cates signiﬁcant difference between the Ultra and speCZT 100 μm scans, and c indicates
ined by two-way repeated measures ANOVA with Bonferroni's post hoc test).
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Bonkowski et al. measured aBMD and BMC in young (6–7weeks), adult
(7–10 months) and aged (28–32 months) mice. In keeping with our
ﬁndings, they reported a large increase associated with growth
(young-adult) and only small changes associated with aging (adult-
aged) (Bonkowski et al., 2006).
Ourmicro-CTmethodology offers the ability to quantify adipose and
lean tissue components of the mouse in addition to measuring the
skeletal tissues. It is known that the C57BL/6 mouse has a propensity
to gain weight with age compared to other mouse models
(Brochmann et al., 2003). Our data conﬁrm other work using DXA
showing a gradual increase in adipose tissue mass percent between 1
and 5 months of age, sharply increasing thereafter up to 12 months of
age (Glatt et al., 2007). Interestingly, our work shows the proportion
of adipose tissue at 2weeks of age is high relative to bodymass,whereas
lean tissue is quite low. These values change drastically at 5 weeks of
age, at which time adipose tissue mass has dropped and lean tissue
mass has increased. Adiposity is important for early survival through
thermal regulation by brown adipose tissue up to ~10 days of age
(Xue et al., 2007). Thereafter, mice begin to develop insulation in the
formofwhite adipose tissue untilweaning at 21days;white adipose tis-
sue then quickly diminishes by 2months of age (Xue et al., 2007; Kozak
et al., 2010). In keeping with these previous studies, our data showed
pronounced subcutaneous adiposity at 2 weeks of age followed by a
drastic reduction at 5 weeks, possibly reﬂecting changes in the require-
ment for thermal insulation. Furthermore, the replacement of adipose
by lean tissuemay reﬂect increased energy demands due to ambulation
and dietary changes post-weaning at 3 weeks of age.
We also found that the maximum value of BMD increases rapidly
until 11 weeks of age, and is then followed by a slow linear increase.
Maximum BMD values represent the degree of mineralization of
compact cortical bone. These values were found to increase with age
and, in older mice, were comparable to values previously reported for
cortical bone BMD in mice (Windahl et al., 1999; Entezari et al., 2012).
As we are reporting maximum BMD values, it is important to note
that these are often higher than values reported in other studies
quantifying mean BMD in ROIs that include both compact bone and
marrow spaces.
In the present study, we provide several measures to evaluate the
internal and external validity of our protocol. First, we measured the
lengths of the tibia and femur to compare them with published values.
Although seemingly straightforward, considerably different measure-
ment methods have been previously reported. Many early studies
measured mouse bone lengths using calipers or micrometer screw
gauges (Somerville et al., 2004); others have used conventional radio-
graphs, pQCT (Beamer et al., 1996), micro-CT (Amblard et al., 2003) or
a combination of manual and imaging techniques (Bagi et al., 2006).
However, precisely deﬁned anatomical beginning and end points for
measurements are not always described. We selected identiﬁable
anatomical landmarks to consistentlymeasure the long bones. Our ﬁnd-
ings correlate well with data from previous reports. Somerville et al.
showed similar changes in tibial length with age in male C57BL/6
mice (Somerville et al., 2004). Somerville's study showed an ~20%
increase in tibia length between 1 and 3 months of age, followed by a
~2.8% increase between 3 and 12 months of age (Somerville et al.,
2004). Our data revealed a ~24% increase in tibia length between 1
and 3 months of age and an ~3.4% increase between 3 and 12 months
of age. Femur lengths of our male mice showed similar patterns to
that of other work in male C57BL/6 mice, with only small increases in
bone length after 2 months of age (Glatt et al., 2007). Speciﬁcally,
Glatt and coworkers showed an ~33% increase in femur length between
1 and 3 months of age, followed by a ~3.9% increase between 3 and
12 months (Glatt et al., 2007). Our data revealed ~30% increase in
femur length between 1 and 3 months of age, followed by a ~6.5%
increase between 3 and 12 months. These ﬁndings help validate our
methodology and establish its reproducibility.As a measure of internal validity, we compared CT-derived total
body masses to gravimetrically measured masses at each age. These
values were in good agreement, with the CT protocol underestimating
total body weight by b3%. This ﬁnding helps establish the accuracy of
our imaging and analysis methods for determining tissue masses.
To assess reproducibility, we scanned two separate cohorts of mice,
both at 8 weeks of age, at different times using the same scanner and
scanning protocol. These data revealed that the two cohorts of mice
had nearly identical distributions of tissue and total body weights. Sta-
bility and reproducibility of the eXplore Locus Ultramicro-CT system it-
self has been previously shown (Du et al., 2007), further solidifying this
assessment. In addition, we scanned one cohort of mice at 2, 5 and
8 weeks of age using two micro-CT systems. We found good
agreement between WBC outputs from scanning on both systems, al-
though it is evident that machine-speciﬁc performance parameters
(e.g., resolution and noise) can inﬂuence measurements. Taken togeth-
er, our ﬁndings establish the validity and reproducibility of this
approach for quantifying whole-body composition in studies of growth
and aging in mice.
Our protocol offers a number of advantages. First, mice are anesthe-
tized by isoﬂurane inhalation, which is less invasive with reduced
adverse effects compared to anesthetic agents that are injected intra-
peritoneally (Szczesny et al., 2004; Fish et al., 2011).Mice recover quick-
ly and repeated use of isoﬂurane is possible without noticeable harm.
Scout scans can be used to determine precise positioning of animals
prior to full scanning. Scans are non-invasive, rapid (as short as 16 s)
and have low-radiation exposures. To establish the radiation safety of
micro-CT scanning, a recent study demonstrated no signiﬁcant effect
on cardiac and pulmonary tissues inmice thatwere purposely delivered
multiple exposures at triple the typical dose of radiation over a 6-week
period (Detombe et al., 2013). Thus, repeated scans can be used to
monitor changes over time in longitudinal studies with minimal con-
cern for adverse effects of radiation. Moreover, analysis using this
whole-body composition method is high-throughput.
There are also some limitations of our protocol that should be noted.
To allow for accurate measurement of WBC andmaintain an acceptably
low radiation dose, the volumes required spatial averaging to lower
resolutions (100 and 150 μm) to diminish noise levels in the images.
Thus, in younger mice with smaller skeletons, skeletal mass and BMD
may be underestimated due to under-mineralization and partial
volume effects arising from increased isotropic voxel spacing. In addi-
tion, to quantify microarchitecture within the trabecular network of
mouse bones, higher scan resolutions are required, as trabeculae are
approximately 30–50 μm in width (Bouxsein et al., 2010). Thus, our
in vivo scans at 50 μm are not capable of imaging small trabecular
struts in mouse bones. Therefore, assessments of mouse bone
microarchitecture must be performed at a scan resolution of ≤20 μm
as post-mortem specimen scans.
Another limitation is that the earliest age that can be assessed is
2 weeks. It is not possible to obtain in vivo data from animals younger
than this, as their bones are not sufﬁciently mineralized to perform
quantiﬁable analyses at these resolutions. In contrast, micro-CT
measurements of ex vivo murine fetal skeletons correlate well with
standard histological techniques in mice as young as gestational day
17–19 (Oest et al., 2008). Furthermore, assessments of whole-mouse
skeletons as young as 2 days of age are feasible when scanning post-
mortem and with higher scan resolutions (Guldberg et al., 2004). To
the best of our knowledge, in vivomicro-CT scanning prior to 2 weeks
of age in mice has yet to be reported. It should also be noted that our
studies were performed on mice with mixed genetic background and
it is likely that our data would not exactly represent parameters in the
original mouse strains. Consequently, it will be of interest in future
studies to compare age-dependent changes in WBC of different strains
of mice.
In summary, the present study is the ﬁrst characterization of chang-
es in WBC during growth and aging of mice using micro-CT. Our
79K.L. Beaucage et al. / Bone Reports 5 (2016) 70–80ﬁndings provide critical reference data for other investigators using
mice as disease models. Additionally, we show marked differences in
WBC values during a period of rapid growth between 2 and 5 weeks
of age, highlighting the importance of collecting data at precise ages
when comparing groups within this range. Moreover, our study
presents an in-depth analysis of WBC using an in-house-designed
micro-CT protocol. This innovative methodology facilitates precise,
long-term, repeated assessment of adipose, lean and skeletal tissues
in vivo in growing and aging mice. Furthermore, our non-invasive
method minimizes the use of research animals, as the mice can be
scanned repeatedly. In addition, the 3D volumes enabled us to precisely
measure growing long bones using consistent anatomical markers.
Our ﬁndings establish that non-invasive single-energy micro-CT is
an accurate and effective tool for high-throughput high-content
characterization of WBC in mouse models.
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